The Intelligent Capsule Endoscopy Robot segmentation by application delineates four primary domains: diagnostic, therapeutic, research, and screening. Diagnostic applications dominate the market, accounting for roughly 45% of total revenue, as hospitals adopt capsule systems to replace conventional endoscopy for gastrointestinal tract visualization, reducing procedural risk and cost. Therapeutic use, representing about 30% of the market, involves capsules equipped with micro‑actuators or drug‑delivery modules that can perform targeted interventions, expanding the technology beyond passive imaging. Research activities, contributing an estimated 15%, focus on algorithm development, sensor integration, and clinical trials, driving innovation and long‑term market sustainability. Finally, screening applications, comprising the remaining 10%, target population‑level health programs for early detection of conditions such as colorectal cancer, where high‑throughput, low‑invasiveness is essential. Collectively, these application categories shape the overall market size by allocating investment, R&D focus, and adoption rates across clinical and commercial settings.